0001022079-24-000033.txt : 20240216
0001022079-24-000033.hdr.sgml : 20240216
20240216200415
ACCESSION NUMBER: 0001022079-24-000033
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240214
FILED AS OF DATE: 20240216
DATE AS OF CHANGE: 20240216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PREVOZNIK MICHAEL E
CENTRAL INDEX KEY: 0001222679
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12215
FILM NUMBER: 24650291
MAIL ADDRESS:
STREET 1: C/O QUEST DIAGNOSTICS
STREET 2: 500 PLAZA DRIVE
CITY: SECAUCUS
STATE: NJ
ZIP: 07094
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC
CENTRAL INDEX KEY: 0001022079
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 161387862
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 PLAZA DRIVE
CITY: SECAUCUS
STATE: NJ
ZIP: 07094
BUSINESS PHONE: 9735202700
MAIL ADDRESS:
STREET 1: 500 PLAZA DRIVE
CITY: SECAUCUS
STATE: NJ
ZIP: 07094
FORMER COMPANY:
FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC
DATE OF NAME CHANGE: 19960903
4
1
wk-form4_1708131839.xml
FORM 4
X0508
4
2024-02-14
0
0001022079
QUEST DIAGNOSTICS INC
DGX
0001222679
PREVOZNIK MICHAEL E
500 PLAZA DRIVE
SECAUCUS
NJ
07094
0
1
0
0
SVP & General Counsel
0
Common Stock
2024-02-14
4
A
0
2935
0
A
41274
D
Common Stock
5540
I
401(k)/SDCP
Non-Qualifed Stock Option (right to buy)
127.805
2024-02-14
4
A
0
12231
0
A
2034-02-14
Common Stock
12231
12231
D
Represents an award of restricted share units.
These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.
The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.
Sean D. Mersten, Attorney in Fact for Michael E. Prevoznik
2024-02-16